This medical education seminar (non-promotional) gives an overview of HS disease burden; the role of MDT care; the use of associated outcome measures and current national guidelines and associated co-morbidities. It discusses the high disease burden; faced by HS patients and the outstanding needs for this patient population. Additionally; the seminar will support clinicians in understanding the evolving outcome measures. The session will give attendees a deeper understanding of the HS patient journey and the need to optimise MDT care for this patient population.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
